Application 203182
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | No | No |
| 002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 10MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-416 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-416 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-416 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-416 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-418 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-418 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-418 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-418 | Cisatracurium | CISATRACURIUM BESYLATE | Fresenius Kabi USA, LLC | ANDA | Current |